GENOME ANNOUNCEMENT
===================

*Babesia divergens* is a tick-borne, intraerythrocytic apicomplexan parasite that causes severe hemolytic anemia in cattle and recently has become a significant zoonotic human pathogen ([@B1]). Infection by blood transfusion is possible as well, as the infected erythrocytes are optimum vehicles for the parasite ([@B2], [@B3]). Erythrocytic invasion is a critical component of the *B. divergens* asexual life cycle, ensuring continual parasite replication in red blood cells (RBCs) ([@B4]) and producing a malaria-like disease. Despite the veterinary and zoonotic importance of this parasite, relatively little research has been carried out on *Babesia*, and many questions regarding the parasite's biology remain unanswered. A better understanding of the species' biology and host-parasite interactions may lead to improved control mechanisms and new trends in vaccine and antibabesial drug development. To facilitate these studies, we sequenced the genome of *B. divergens* human isolate (Rouen 1987) combining three different sequencing platforms to produce a high-quality draft genome.

Genomic DNA was isolated ([@B5], [@B6]) from *B. divergens* human RBC cultures ([@B7]). The genome was assembled in three stages. First, a total of 34,182,568 reads, representing 310× coverage, produced with the Illumina HiSeq 2000 platform, were assembled using ALLPATHS-LG ([@B8]). Second, 829,056 reads, representing a 23× coverage produced by 454, were assembled using Newbler v. 2.8 and adding the Illumina scaffolds as overlapping "fake" Sanger reads. Third, 109,329 PacBio reads from one SMRT cell run (P4/C2 chemistry) were used to close gaps or extend contig ends in the Illumina+454 hybrid assembly using PBJelly ([@B9]). Finally, ICORN2 ([@B10]) was used for platform-specific base error corrections. The final assembly had 10,797,556 bp in 514 scaffolds, with *N*~50~/*N*~90~ values of 1,084,746/6,917 bp, respectively. The GC content was 40%, similar to other *Babesia* genomes ([@B11], [@B12]). However, the estimated genome size read k-mer content (\~11.5 Mbp) exceeded the observed size in other *Babesia* species and in other *B. divergens* strains (\~9 Mbp) ([@B11][@B12][@B13]). This could be due to a different repeat content (\~30%) or small contigs containing genes with several haplotypes that were not resolved by the assemblers. While this work was in progress, the genomes of *B. divergens* strains (Rouen 1987 and 1802 A strains) were published ([@B12]). The Rouen 1987 sequence was reported as a very fragmented assembly with an arbitrary scaffold ordering. In contrast, our assembly contained very large scaffolds where a high number of telomeric repeats are found, indicating reconstruction of almost complete chromosomes. Using CEGMA v. 2.5 ([@B14]), we obtained 80% completeness of the genome. Protein-coding genes (3,741) predicted using Augustus ([@B15]) and the CEGMA completion level obtained were very similar to those for the recently published *B. divergens* genome ([@B12]), although the degree of continuity obtained in our study is superior, as presented in the assembly statistics.

Therefore, the *B. divergens* genome presented here can be used as a reference to study its genome structure in order to understand the regulation of its genes and probe shared synteny with other *Apicomplexan* species.

Nucleotide sequence accession numbers. {#h1}
--------------------------------------

This genome shotgun project has been deposited at the European Nucleotide Archive under the accession numbers [CCSG01000001](http://www.ebi.ac.uk/ena/data/view/CCSG01000001) to [CCSG01000514](http://www.ebi.ac.uk/ena/data/view/CCSG01000514).
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